ESR1 and myeloid sarcoma: Previous studies investigating the therapeutic effects of estrogen receptors (Erβ) ligands such as estriol, diarylpropionitrile, and indazole-Cl on EAE model of MS did not show noticeable changes between male and female mice [28,75,76,77].